| 000 | 01488 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513232602.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a1462-8902 | ||
| 024 | 7 |
_a10.1046/j.1463-1326.2000.00073.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGüler, S | |
| 245 | 0 | 0 |
_aLeptin concentrations are related to glycaemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cOct 2000 |
||
| 300 |
_a313-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDiet, Diabetic |
| 650 | 0 | 4 | _aFasting |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlipizide _xtherapeutic use |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLeptin _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aRegression Analysis |
| 700 | 1 | _aCakir, B | |
| 700 | 1 | _aDemirbaş, B | |
| 700 | 1 | _aGürsoy, G | |
| 700 | 1 | _aSerter, R | |
| 700 | 1 | _aAral, Y | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 2 _gno. 5 _gp. 313-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1463-1326.2000.00073.x _zAvailable from publisher's website |
| 999 |
_c11163524 _d11163524 |
||